These resources include: A CISP Checklist Implementing Revised List (available now) Athlete and ASP Guide to the 2026 List (to be available mid-December) Languages and formats The 2026 Prohibited List, the 2026 Summary of Modifications and Explanatory Notes, and the 2026 Monitoring Program are available for download on WADAs website in English and French, with Spanish to follow in the coming weeks
Medically Reviewed By: Karla K
Adults on GLP-1 receptor agonists for extended periods show reduced risk of cognitive decline and dementia in several observational and trial datasets, with effect sizes ranging from modest single-digit reductions to much larger ones, depending on the cohort
After 12-hours of night fasting, blood samples were taken for the measurement of CRP, basal glucose level, lipid profile, serum creatinine, urea and uric acid levels, and morphology of peripheral blood
Gupta AK et al
Additionally, AOD-9604 obtained FDA GRAS (Generally Recognized as Safe) status as a food ingredient based on the oral clinical trial data